Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
OTLK on Nasdaq
Shares outstanding
67,246,397
Price per share
$0.46
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,820,738
Total reported value
$10,777,068
% of total 13F portfolios
0%
Share change
+2,400,449
Value change
+$3,854,437
Number of holders
51
Price from insider filings
$0.46
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GMS Ventures & Investments 50% +21% $45,303,849 +$20,057,142 29,040,929 +79% GMS VENTURES & INVESTMENTS 27 May 2025
SPHERA FUNDS MANAGEMENT LTD. 4.7% -40% $4,983,092 +$920,239 3,153,856 +23% Sphera Funds Management Ltd. 31 Dec 2025
Empery Asset Management, LP 5% -32% $2,472,925 -$914,455 2,332,948 -27% Empery Asset Management, LP 30 Sep 2025
GREAT POINT PARTNERS LLC 5% -23% $4,484,400 2,220,000 0% Great Point Partners, LLC 30 Jun 2025
TANG CAPITAL PARTNERS LP 6.4% $2,624,703 1,682,502 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024
TANG CAPITAL MANAGEMENT LLC 3.4% -37% $3,030,000 -$808,000 1,500,000 -21% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025

As of 31 Dec 2025, 51 institutional investors reported holding 6,820,738 shares of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK). This represents 10% of the company’s total 67,246,397 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) together control 10% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Schonfeld Strategic Advisors LLC 3.6% 2,441,355 +241% 0.02% $3,857,338
VANGUARD GROUP INC 2.2% 1,465,167 +9.1% 0% $2,314,964
BlackRock, Inc. 0.6% 404,542 +9.4% 0% $639,177
GILPIN WEALTH MANAGEMENT, LLC 0.53% 354,200 0% 0.44% $559,636
GEODE CAPITAL MANAGEMENT, LLC 0.47% 316,464 +3.3% 0% $500,120
MARSHALL WACE, LLP 0.44% 298,456 0% $471,560
UBS Group AG 0.31% 209,540 +336% 0% $331,073
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.26% 172,022 -19% 0% $271,795
MILLENNIUM MANAGEMENT LLC 0.24% 164,498 -15% 0% $259,907
STATE STREET CORP 0.24% 163,102 +117% 0% $257,701
COMMONWEALTH EQUITY SERVICES, LLC 0.17% 112,500 -0.58% 0% $177,750
SIMPLEX TRADING, LLC 0.16% 105,797 +19% 0% $167,159
JANE STREET GROUP, LLC 0.16% 104,662 +305% 0% $165,366
SCOTIA CAPITAL INC. 0.11% 73,989 0% 0% $116,903
NORTHERN TRUST CORP 0.1% 67,390 +159% 0% $106,476
LVW Advisors, LLC 0.07% 48,235 0% 0.01% $76,212
GOLDMAN SACHS GROUP INC 0.07% 45,782 +6.5% 0% $72,336
Vontobel Holding Ltd. 0.06% 40,000 0% $63,200
GROUP ONE TRADING LLC 0.06% 36,997 +120% 0% $58,455
XTX Topco Ltd 0.04% 30,224 +175% 0% $47,754
Christensen, King & Associates Investment Services, Inc. 0.04% 28,327 +4.1% 0.02% $44,757
LPL Financial LLC 0.03% 21,794 -23% 0% $34,435
Flower City Capital 0.03% 20,000 0% 0.02% $31,600
Vanguard Personalized Indexing Management, LLC 0.02% 15,605 +12% 0% $24,656
PNC Financial Services Group, Inc. 0.02% 15,000 +30% 0% $23,700

Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,820,738 $10,777,068 +$3,854,437 $1.58 51
2025 Q3 4,077,199 $4,321,292 -$2,295,785 $1.06 53
2025 Q2 5,938,598 $9,501,555 -$1,298,121 $1.60 63
2025 Q1 7,084,422 $8,644,858 +$2,800,480 $1.22 61
2024 Q4 4,545,632 $8,587,260 -$17,551,788 $1.89 60
2024 Q3 7,927,898 $42,334,234 -$3,223,883 $5.34 65
2024 Q2 8,042,692 $59,354,216 +$2,234,341 $7.38 63
2024 Q1 7,236,418 $86,189,121 +$86,127,774 $11.94 53
2023 Q3 34,194 $7,557 $0.22 1
2023 Q2 34,194 $59,498 $1.74 1
2023 Q1 34,194 $37,271 +$37,271 $1.09 1